Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Neuro-Oncology and Neurosurgical Oncology

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1614678

Deep Learning and Pathomics Analyses predict prognosis of high-grade gliomas

Provisionally accepted
Yuchen  ZhuYuchen Zhu1Yuxi  GongYuxi Gong1Weilin  XuWeilin Xu1Xingjian  SunXingjian Sun1Gefei  JiangGefei Jiang1Lei  QiuLei Qiu1Kexin  ShiKexin Shi1Wu  MengxingWu Mengxing1Yinjiao  FeiYinjiao Fei1Jinling  YuanJinling Yuan1Jinyan  LuoJinyan Luo1Yurong  LiYurong Li2Yuandong  CaoYuandong Cao1Minhong  PanMinhong Pan1SHU  ZHOUSHU ZHOU1*
  • 1First Affiliated Hospital, Nanjing Medical University, Nanjing, China
  • 2Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

The final, formatted version of the article will be published soon.

Utilizing pathomics to analyze high-grade gliomas and provide prognostic insights. Initially, regions of interest (ROIs) within the entire slice images (WSIs) were identified and underwent cropping, removal of blank areas, and standardization to select tumor patches. Subsequently, a deep learning model trained on these patches aggregated predictions for WSIs. Finally, pathological features were extracted using Pearson correlation, univariate Cox regression, and LASSO-Cox regression, and three models were developed: a pathology-based model, a clinical model, and a combined model integrating both. In the study, the combined model demonstrated the best performance, with a C-index of 0.847 in the training set and 0.739 in the test set. Based on the combined model, the patient population was divided into high-risk and low-risk groups.The median progression-free survival (PFS) for high-risk patients was 10 months (p<0.001), while the median PFS for low-risk patients was not reached. Stratification by IDH status revealed significant differences in PFS. In conclusion, the combined model can better predict the progression risk of high-grade gliomas and provides valuable guidance for personalized treatment of high-grade gliomas.

Keywords: high-grade gliomas, deep learning, prognostic analysis, Pathomics, IDH

Received: 19 Apr 2025; Accepted: 18 Jul 2025.

Copyright: © 2025 Zhu, Gong, Xu, Sun, Jiang, Qiu, Shi, Mengxing, Fei, Yuan, Luo, Li, Cao, Pan and ZHOU. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: SHU ZHOU, First Affiliated Hospital, Nanjing Medical University, Nanjing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.